World's Best Scientists 2026 revealed!

D-Index & Metrics

Biology and Biochemistry

D-Index
63
Citations
15044
World Ranking
10163
National Ranking
4442

Federico Innocenti publication distribution in Biology and Biochemistry in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Biology and Biochemistry in 2026. The highlighted bar marks where Federico Innocenti sits on this spectrum.

47–56 publications: 8 scientists 57–66 publications: 35 scientists 67–76 publications: 106 scientists 77–86 publications: 231 scientists 87–96 publications: 414 scientists 97–106 publications: 546 scientists 107–116 publications: 704 scientists 117–126 publications: 849 scientists 127–136 publications: 980 scientists 137–146 publications: 942 scientists 147–156 publications: 969 scientists 157–166 publications: 950 scientists 167–176 publications: 951 scientists 177–186 publications: 915 scientists 187–196 publications: 787 scientists 197–206 publications: 841 scientists 207–216 publications: 735 scientists 217–226 publications: 709 scientists 227–236 publications: 651 scientists 237–246 publications: 605 scientists 247–256 publications: 510 scientists 257–266 publications: 524 scientists 267–276 publications: 434 scientists 277–286 publications: 418 scientists 287–296 publications: 350 scientists 297–306 publications: 363 scientists 307–316 publications: 315 scientists 317–326 publications: 296 scientists 327–336 publications: 261 scientists 337–346 publications: 240 scientists 347–356 publications: 219 scientists 357–366 publications: 197 scientists 367–376 publications: 154 scientists 377–386 publications: 161 scientists 387–396 publications: 155 scientists 397–406 publications: 145 scientists 407–416 publications: 124 scientists 417–426 publications: 112 scientists 427–436 publications: 132 scientists 437–446 publications: 116 scientists 447–456 publications: 99 scientists 457–466 publications: 81 scientists 467–476 publications: 91 scientists 477–486 publications: 80 scientists 487–496 publications: 80 scientists 497–506 publications: 60 scientists 507–516 publications: 36 scientists 517–526 publications: 46 scientists 527–536 publications: 54 scientists 537–546 publications: 44 scientists 547–556 publications: 43 scientists 557–566 publications: 43 scientists 567–576 publications: 42 scientists 577–586 publications: 25 scientists 587–596 publications: 34 scientists 597–606 publications: 23 scientists 607–616 publications: 33 scientists 617–626 publications: 31 scientists 627–636 publications: 27 scientists 637–646 publications: 25 scientists 647–656 publications: 28 scientists 657–666 publications: 34 scientists 667–676 publications: 18 scientists 677–686 publications: 16 scientists 687–696 publications: 10 scientists 697–706 publications: 12 scientists 707–716 publications: 21 scientists 717–726 publications: 12 scientists 727–736 publications: 12 scientists 737–746 publications: 10 scientists 747–756 publications: 7 scientists 757–766 publications: 13 scientists 767–776 publications: 15 scientists 777–786 publications: 13 scientists 787–796 publications: 9 scientists 797–806 publications: 9 scientists 807–816 publications: 7 scientists 817–826 publications: 4 scientists 827–836 publications: 9 scientists 837–846 publications: 7 scientists 847–856 publications: 3 scientists 857–866 publications: 5 scientists 867–876 publications: 5 scientists 877–886 publications: 11 scientists 887–896 publications: 3 scientists 897–906 publications: 4 scientists 907–916 publications: 7 scientists 917–926 publications: 5 scientists 927–936 publications: 6 scientists 937–946 publications: 6 scientists 947–956 publications: 3 scientists 957–966 publications: 7 scientists 967–976 publications: 2 scientists 977–986 publications: 2 scientists 987–996 publications: 1 scientists 997–1,006 publications: 5 scientists 1,007–1,016 publications: 2 scientists 1,017–1,026 publications: 2 scientists 1,027 publications: 1 scientists 1,028+ publications: 100 scientists
47 publications 1,028+

This scientist: 433 publications — 92nd percentile

92% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,028 publications or more.

Federico Innocenti D-index placement in Biology and Biochemistry in 2026

The chart shows the D-index (discipline H-index) distribution of Biology and Biochemistry scientists ranked by Research.com in 2026. The highlighted bar marks where Federico Innocenti sits on this spectrum.

40–41 D-Index: 80 scientists 42–43 D-Index: 183 scientists 44–45 D-Index: 317 scientists 46–47 D-Index: 504 scientists 48–49 D-Index: 718 scientists 50–51 D-Index: 900 scientists 52–53 D-Index: 1,026 scientists 54–55 D-Index: 1,150 scientists 56–57 D-Index: 1,236 scientists 58–59 D-Index: 1,253 scientists 60–61 D-Index: 1,163 scientists 62–63 D-Index: 1,131 scientists 64–65 D-Index: 1,032 scientists 66–67 D-Index: 897 scientists 68–69 D-Index: 814 scientists 70–71 D-Index: 715 scientists 72–73 D-Index: 709 scientists 74–75 D-Index: 596 scientists 76–77 D-Index: 512 scientists 78–79 D-Index: 473 scientists 80–81 D-Index: 412 scientists 82–83 D-Index: 373 scientists 84–85 D-Index: 358 scientists 86–87 D-Index: 285 scientists 88–89 D-Index: 273 scientists 90–91 D-Index: 227 scientists 92–93 D-Index: 208 scientists 94–95 D-Index: 193 scientists 96–97 D-Index: 153 scientists 98–99 D-Index: 157 scientists 100–101 D-Index: 148 scientists 102–103 D-Index: 120 scientists 104–105 D-Index: 113 scientists 106–107 D-Index: 100 scientists 108–109 D-Index: 86 scientists 110–111 D-Index: 67 scientists 112–113 D-Index: 72 scientists 114–115 D-Index: 73 scientists 116–117 D-Index: 64 scientists 118–119 D-Index: 53 scientists 120–121 D-Index: 60 scientists 122–123 D-Index: 54 scientists 124–125 D-Index: 43 scientists 126–127 D-Index: 38 scientists 128–129 D-Index: 49 scientists 130–131 D-Index: 26 scientists 132–133 D-Index: 18 scientists 134–135 D-Index: 23 scientists 136–137 D-Index: 32 scientists 138–139 D-Index: 32 scientists 140–141 D-Index: 27 scientists 142–143 D-Index: 19 scientists 144–145 D-Index: 22 scientists 146–147 D-Index: 12 scientists 148–149 D-Index: 16 scientists 150–151 D-Index: 14 scientists 152–153 D-Index: 10 scientists 154–155 D-Index: 13 scientists 156–157 D-Index: 10 scientists 158–159 D-Index: 7 scientists 160–161 D-Index: 9 scientists 162–163 D-Index: 13 scientists 164–165 D-Index: 4 scientists 166 D-Index: 4 scientists 167+ D-Index: 98 scientists
40 D-Index 167+

This scientist: 63 D-Index — 49th percentile

49% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 167 D-Index or more.

Overview

Federico Innocenti is affiliated with the University of North Carolina at Chapel Hill in the United States. Their research primarily spans the fields of Medicine and Biochemistry, Genetics, and Molecular Biology, with a focus on Oncology, Molecular Biology, Cancer Research, Pathology and Forensic Medicine, and Pulmonary and Respiratory Medicine.

Their scholarly contributions emphasize key topics including Colorectal Cancer Treatments and Studies, Cancer Genomics and Diagnostics, Genetic factors in colorectal cancer, Cancer therapeutics and mechanisms, Epigenetics and DNA Methylation, Lung Cancer Research Studies, and Gastric Cancer Management and Outcomes.

Significant recent publications illustrate the scope of Federico Innocenti's work. These include:

  • ctDNA applications and integration in colorectal cancer: an NCI Colon and Rectal-Anal Task Forces whitepaper (2020), Nature Reviews Clinical Oncology
  • Liposomal irinotecan (Onivyde): Exemplifying the benefits of nanotherapeutic drugs (2022), Cancer Science
  • Effect of First-Line Chemotherapy Combined With Cetuximab or Bevacizumab on Overall Survival in Patients With KRAS Wild-Type Advanced or Metastatic Colorectal Cancer: A Randomized Clinical Trial (2020), UNC Libraries
  • All You Need to Know About DPYD Genetic Testing for Patients Treated With Fluorouracil and Capecitabine: A Practitioner-Friendly Guide (2020), JCO Oncology Practice
  • Genetic effects on liver chromatin accessibility identify disease regulatory variants (2021), The American Journal of Human Genetics

The scientist frequently collaborates with the following coauthors:

  • Alan P. Venook
  • Heinz-Josef Lenz
  • Fang-Shu Ou
  • Amy S. Etheridge
  • Richard M. Goldberg

Their research has been published extensively in various venues, with a particular concentration in:

  • UNC Libraries
  • Journal of Clinical Oncology
  • The Pharmacogenomics Journal
  • Cancer Research
  • JCO Oncology Practice

Best Publications

  • Comprehensive and Integrative Genomic Characterization of Hepatocellular Carcinoma

    Adrian Ally;Miruna Balasundaram;Rebecca Carlsen;Eric Chuah

  • Genetic variants in the UDP-glucuronosyltransferase 1A1 gene predict the risk of severe neutropenia of irinotecan.

    Federico Innocenti;Samir D. Undevia;Lalitha Iyer;Pei Xian Chen

  • Gemcitabine Plus Bevacizumab Compared With Gemcitabine Plus Placebo in Patients With Advanced Pancreatic Cancer: Phase III Trial of the Cancer and Leukemia Group B (CALGB 80303)

    Hedy Lee Kindler;Donna Niedzwiecki;Donna Hollis;Susan Sutherland

  • Effect of First-Line Chemotherapy Combined With Cetuximab or Bevacizumab on Overall Survival in Patients With KRAS Wild-Type Advanced or Metastatic Colorectal Cancer: A Randomized Clinical Trial

    Alan P. Venook;Donna Niedzwiecki;Heinz Josef Lenz;Federico Innocenti

  • CALGB/SWOG 80405: Phase III trial of irinotecan/5-FU/leucovorin (FOLFIRI) or oxaliplatin/5-FU/leucovorin (mFOLFOX6) with bevacizumab (BV) or cetuximab (CET) for patients (pts) with KRAS wild-type (wt) untreated metastatic adenocarcinoma of the colon or rectum (MCRC).

    Alan P. Venook;Donna Niedzwiecki;Heinz-Josef Lenz;Federico Innocenti

  • Impact of primary (1{o}) tumor location on overall survival (OS) and progression-free survival (PFS) in patients (pts) with metastatic colorectal cancer (mCRC): Analysis of CALGB/SWOG 80405 (Alliance).

    Alan P. Venook;Donna Niedzwiecki;Federico Innocenti;Briant Fruth

  • ctDNA applications and integration in colorectal cancer: an NCI Colon and Rectal-Anal Task Forces whitepaper.

    Arvind Dasari;Van K. Morris;Carmen J. Allegra;Chloe Atreya

  • Genome-wide association study identifies multiple susceptibility loci for pancreatic cancer

    Brian M. Wolpin;Cosmeri Rizzato;Peter Kraft;Charles Kooperberg

  • Predictive Role of the UGT1A1, UGT1A7, and UGT1A9 Genetic Variants and Their Haplotypes on the Outcome of Metastatic Colorectal Cancer Patients Treated With Fluorouracil, Leucovorin, and Irinotecan

    Erika Cecchin;Federico Innocenti;Mario D'Andrea;Giuseppe Corona

  • Comprehensive Pharmacogenetic Analysis of Irinotecan Neutropenia and Pharmacokinetics

    Federico Innocenti;Deanna L. Kroetz;Erin Schuetz;M. Eileen Dolan

  • Mutational Analysis of Patients With Colorectal Cancer in CALGB/SWOG 80405 Identifies New Roles of Microsatellite Instability and Tumor Mutational Burden for Patient Outcome

    Federico Innocenti;Fang Shu Ou;Xueping Qu;Tyler J. Zemla

  • Identification, Replication, and Functional Fine-Mapping of Expression Quantitative Trait Loci in Primary Human Liver Tissue

    Federico Innocenti;Gregory M. Cooper;Ian B. Stanaway;Eric R. Gamazon

  • Impact of Consensus Molecular Subtype on Survival in Patients With Metastatic Colorectal Cancer: Results From CALGB/SWOG 80405 (Alliance).

    Heinz Josef Lenz;Fang Shu Ou;Alan P. Venook;Howard S. Hochster

  • Ethnic Differences and Functional Analysis of MET Mutations in Lung Cancer

    Soundararajan Krishnaswamy;Rajani Kanteti;Jonathan S. Duke-Cohan;Sivakumar Loganathan

  • A Functional Common Polymorphism in a Sp1 Recognition Site of the Epidermal Growth Factor Receptor Gene Promoter

    Wanqing Liu;Federico Innocenti;Michael H. Wu;Apurva A. Desai

  • Variation in the glucose transporter gene SLC2A2 is associated with glycemic response to metformin.

    Kaixin Zhou;Sook Wah Yee;Eric L Seiser;Nienke van Leeuwen

  • Effect of methylenetetrahydrofolate reductase 677C-->T polymorphism on toxicity and homocysteine plasma level after chronic methotrexate treatment of ovarian cancer patients.

    Giuseppe Toffoli;Antonio Russo;Federico Innocenti;Giuseppe Corona

  • A pharmacogenetic study of uridine diphosphate-glucuronosyltransferase 2B7 in patients receiving morphine.

    Michael B. Sawyer;Michael B. Sawyer;Federico Innocenti;Federico Innocenti;Soma Das;Soma Das;Cheng Cheng;Cheng Cheng

  • Haplotype structure of the UDP-glucuronosyltransferase 1A1 promoter in different ethnic groups.

    Federico Innocenti;Carrie Grimsley;Soma Das;Jacqueline Ramírez

  • Genotype-Driven Phase I Study of Irinotecan Administered in Combination With Fluorouracil/Leucovorin in Patients With Metastatic Colorectal Cancer

    Giuseppe Toffoli;Erika Cecchin;Giampiero Gasparini;Mario D'andrea

Frequent Co-Authors

Mark J. Ratain
Mark J. Ratain University of Chicago
Alan P. Venook
Alan P. Venook University of California, San Francisco
Donna Niedzwiecki
Donna Niedzwiecki Duke University
Heinz-Josef Lenz
Heinz-Josef Lenz University of Southern California
Charles D. Blanke
Charles D. Blanke Oregon Health & Science University
Richard M. Goldberg
Richard M. Goldberg West Virginia University
Robert J. Mayer
Robert J. Mayer Dana-Farber Cancer Institute
Monica M. Bertagnolli
Monica M. Bertagnolli Brigham and Women's Hospital
Jeffrey A. Meyerhardt
Jeffrey A. Meyerhardt Harvard University
Soma Das
Soma Das University of Chicago

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying Biology and Biochemistry in the USA opens doors to diverse and rewarding careers. For those interested in allied health, fitness, or rehabilitation, pursuing the best online kinesiology degree can be a great next step. Kinesiology applies biological principles to human movement and exercise sciences.

Healthcare remains a top destination for biology graduates. Many professionals are seeking advanced credentials with flexible schedules. Options like the fastest post master's pmhnp and the shortest online nurse practitioner program offer efficient pathways for nurses to specialize and increase their earning potential.

Nutrition is another growing field for science graduates. Earning an online nutritionist degree is now more accessible and affordable than ever. These degrees prepare students for roles in health promotion, wellness coaching, and clinical nutrition.

Exploring these related programs can help you expand your skills, qualify for new roles, and adapt to the evolving landscape of science and healthcare careers.

Best Scientists Citing Federico Innocenti

Trending Scientists

Recently Published Articles